Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells.

@article{Yamasaki2009EffectsOA,
  title={Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells.},
  author={Daisuke Yamasaki and Tsutomu Nakamura and Noboru Okamura and Makiko Kokudai and Naoki Inui and Kazuhiko Takeuchi and Hiroshi Watanabe and Midori Hirai and Katsuhiko Okumura and Toshiyuki Sakaeda},
  journal={European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  year={2009},
  volume={37 2},
  pages={
          126-32
        }
}
  • D. Yamasaki, Tsutomu Nakamura, +7 authors T. Sakaeda
  • Published 2009
  • Biology, Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
In the present study, the ability of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), also known as statins, to regulate the gene expression and function of multidrug resistance protein 1 (MDR1/P-glycoprotein) and differences between their acid and lactone forms were examined in human intestinal epithelial LS180 cells. Some statins had the potential to induce the expression of mRNAs for MDR1 and/or CYP3A in either form. The change in the mRNA expression of MDR1 was… Expand
In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compounds.
TLDR
Given the marginal effects on NF-ĸB, PXR, expression levels of selected P XR target genes, and activities of important drug transporters and CYP3A4 in vitro, resiquimod is not expected to cause major pharmacokinetic drug-drug interactions in vivo. Expand
Optical Isomers of Atorvastatin, Rosuvastatin and Fluvastatin Enantiospecifically Activate Pregnane X Receptor PXR and Induce CYP2A6, CYP2B6 and CYP3A4 in Human Hepatocytes
TLDR
The activity of P450 transcriptional regulators, including pregnane X receptor (PXR), aryl hydrocarbon receptor (AhR) and glucocorticoid receptor (GR), was assessed, and the potency and efficacy between individual optical isomers varied depending on statin and optical isomer. Expand
Time-Resolved Effect of Interferon-Alpha 2a on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes
TLDR
IFN-α 2a demonstrated short-term suppressive effects on PXR activity and CYP3A4 mRNA expression, likely mediated by activated NF-ĸB. Expand
Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions.
TLDR
The data suggest a low potential of camostat mesylate to act as a perpetrator in pharmacokinetic drug-drug interactions, and only inhibition of OATP2B1 by GBPA warrants further investigation. Expand
Desmethyl bosentan displays a similar in vitro interaction profile as bosentan.
TLDR
It is demonstrated that desmethyl bosentan exhibits a similar pharmacokinetic interaction profile as bosENTan and might contribute to the inducing effects of the parent compound. Expand
The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes
TLDR
A novel regulatory loop is described, whereby activation of FXR by statins increases PXR reporter gene expression, potentially enhancing PxR-mediated responses, and has important potential implications for their use within a polypharmacy paradigm. Expand
Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes.
TLDR
Atorvastatin impaired glucose utilization in hepatocytes via repressing GLUT2 and GCK expressions, which may be partly due to PXR activation. Expand
Simvastatin effects on detoxification mechanisms in Danio rerio embryos
TLDR
The interaction of simvastatin with detoxification mechanisms highlighting the importance of monitoring the presence of this emerging contaminant in aquatic environments is revealed. Expand
Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro
TLDR
It is indicated that dovitinib will most likely retain its efficacy in tumours over-expressing P-gp or BCRP and this work gives first evidence thatDovit inib might act as a perpetrator drug in pharmacokinetic drug–drug interactions. Expand
Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills
TLDR
The pattern of differentially expressed genes in rainbow trout gills differ from responses previously observed in mammalian tissues following statin exposure, and there were no significant changes in gill Na+/K+ ATPase activity following exposure to atorvastatin. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 43 REFERENCES
A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.
TLDR
In human liver microsomes, all the lactone forms tested inhibited the oxidative metabolism of mexazolam more strongly than did the acid forms, which have lower partition coefficient values, and pravastatin (acid form), which has the lowest logD(7.0) value, failed to inhibit CYP3A4 activity. Expand
Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport
TLDR
The difference between the acid and lactone forms in terms of drug interaction was showed, and a significant correlation was found between the lipophilicity and inhibitory effects on CYP2C8-mediated paclitaxel 6α-hydroxylation. Expand
DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1
TLDR
The interconversion between the lactone and acid forms of most statins exists in the body and will potentially influence drug-transporter interactions, and may ultimately contribute to the differences in pharmacokinetic profiles observed between statins. Expand
Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver.
  • T. Kocarek, A. B. Reddy
  • Biology, Medicine
  • Drug metabolism and disposition: the biological fate of chemicals
  • 1996
TLDR
Comparisons of the effects of lovastatin with those of three additional HMG-CoA reductase inhibitors on P450 expression in primary cultured rat hepatocytes and in vivo with in vivo treatment with fluvastatin suggest that simple inhibition of H MG- CoA reduCTase cannot explain all of the results of these drugs on P 450 expression. Expand
Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors
TLDR
It is demonstrated that CYP-mediated metabolism of lactones is also a common metabolic pathway for statins and that the CYP3A4- mediated metabolism of the lactone forms clearly will need to be taken into account in assessing mechanistic aspects of drug–drug interaction involving statins. Expand
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.
TLDR
This review presents a quantitative analysis of the effect of some factors on the pharmacokinetics of statins based on a physiologically based pharmacokinetic model and suggests that model-based prediction is also useful. Expand
Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in Cancer*
TLDR
It is concluded that survivin down-regulation is crucial in Lovastatin-induced apoptosis in cancer cells and that lovastatin decreases survivin expression by inhibiting Ras-mediated PI3-kinase activation via the blocking of Ras isoprenylation. Expand
A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression
TLDR
It is demonstrated by gel shift and transfection experiments that CAR binds to distinct nuclear receptor response elements in the -7.8 kbp enhancer of MDR1 and transactivates MDR 1 expression through DR4 motifs to which the receptor binds as a heterodimer with RXR or as a monomer, respectively. Expand
The Peripheral Benzodiazepine Receptor Ligand 1-(2-Chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide Is a Novel Antagonist of Human Constitutive Androstane Receptor
TLDR
1-(2-chlorophenylmethylpropyl)-3-isoquinoline-carboxamide (PK11195), a typical peripheral benzodiazepine receptor (PBR) ligand, is identified as a selective and potent inhibitor of human (h) CAR and can be used as a chemical tool for studying the molecular basis of CAR function. Expand
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.
TLDR
The identification of a human (h) orphan nuclear receptor, termed the pregnane X receptor (PXR), that binds to a response element in the CYP3A4 promoter and is activated by a range of drugs known to induce CYP 3A4 expression is reported. Expand
...
1
2
3
4
5
...